Colorado Tick Fever Antibody Panel, IFA
Test Code
34986
86790 (x2)
Clinical Significance
Colorado Tick Fever Antibody Panel, IFA - Recent or current Colorado Tick Fever is indicated by a four-fold or greater rise in IgG titer between acute and convalescent sera and/or an IgM level of 1:20 or greater.
Test Resources
Test Details
Colorado Tick Fever IgG and Colorado Tick Fever IgM
Methodology
Immunoassay (IA)
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range(s)
| Colorado Tick Fever Ab (IgG) | <1:16 titer |
| Colorado Tick Fever Ab (IgM) | <1:20 titer |
Preferred Specimen(s)
1 mL serum
Minimum Volume
0.25 mL
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 7 days
- Refrigerated: 14 days
- Frozen: 30 days
Reject Criteria
Gross hemolysis • Lipemia • Icteric
Setup Schedule
1 mL serum
0.25 mL
Transport tube
Room temperature
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Gross hemolysis • Lipemia • Icteric